Media Coverage

Dechra launches respiratory aid for livestock

May 11, 2017 - Animal Pharm

By Malcolm Flanagan
Animal Pharm
May 9, 2017

UK animal health company Dechra Pharmaceuticals has launched a new antibiotic solution for the mass treatment of respiratory disease in chickens and swine.

Metaxol contains 20mg trimethoprim and 100mg sulfamethoxazole per ml and can be added directly to drinking water or used in a concentrated stock. It has been launched across the UK and the EU. The product was approved by the EU in 2016.

Dechra said Metaxol, which is part of the firm's SoluStab range, is replacing its established Methoxasol product. The Northwich-headquartered company said Metaxol is likely to be welcomed by farmers wanting to target entire flocks thanks to its shorter withdrawal time for broilers.

In broilers, it can be used for treatment and metaphylaxis of colibacillosis caused by E coli susceptible to trimethoprim-sulfamethoxazole or coryza caused by Avibacterium paraga. The recommended dosage is 0.25ml of product per kg body weight every day for four to seven days for pigs and 0.38ml of product per kg body weight every day for three days for chickens.

In fattening pigs, it is suitable for the treatment and metaphylaxis of post-weaning diarrhea caused by beta-hemolytic K88-positive, K99-positive or 987P Ecoli strains susceptible to trimethoprim-sulfamethoxazole. It can also be used for secondary bacterial infections caused by Pasteurella multocidaActinobacillus pleuropneumoniaeStreptococcus spp and Haemophilus parasuis susceptible to trimethoprim-sulfamethoxazole.

Dechra brand manager Emma Jennings said: "Sulfamethoxazole is a potent sulfonamide and, when combined with trimethoprim, it has a synergistic and bactericidal effect. Both active ingredients are rapidly absorbed and distributed widely in tissues making it a highly effective treatment. The shorter withdrawal time for broilers will make it an attractive treatment for farmers wanting to target entire flocks."

UK animal health company ECO Animal Health also has an antibiotic treatment, Aivlosin, for respiratory diseases in poultry and pigs. It was approved in the EU in June 2016.

Reprinted with permission of Animal Pharm News




News Releases

Inside the Corridor

KC Animal Health Blog

Investment Forum